|
| INTRO EQUATIONS CRITERIA DECISION CONVERT SPECIALTIES REFS SEARCH NEW FHIR APP POLICIES CONTACT |
| Medical Equations |
- Absolute Lymphocyte Count
- Absolute Neutrophil Count
- Absolute Phagocyte Count
- Absolute Reticulocyte Count
- Albumin-bilirubin (ALBI) grade estimate of survival of adults with hepatocellular carcinoma (conventional and SI units)
- Body Surface Area (BSA, Gehan and George Method)
- Mantle Cell Lymphoma International Prognostic Index (MIPI)
- Sodium Change in Hyperproteinemia
| Clinical Criteria |
- Breast Cancer Recurrence Risk After Mastectomy (simple)
- Breast cancer risk assessment by Gail Model (2018)
- Breast cancer risk assessment incorporating breast density (BCSC 2015)
- Cancer and Aging Research Group-Breast Cancer (CARG-BC) score for older adults
- ECOG Performance Status
- ICE Score: Immune Effector Cell-Associated Encephalopathy
- International Prognostic Index for Non-Hodgkin Lymphoma
- International Prognostic Score in Hodgkin Lymphoma (1998)
- International Prognostic Score in Hodgkin Lymphoma (2012 update)
- Khorana Score for Estimating Venous Thromboembolism Risk in Adults with Cancer
- Light's Criteria for Exudative Pleural Effusion
- Low anterior resection syndrome (LARS) score
- Lung Cancer One Year Risk Estimation (for smokers 50-75 years old)
- Lung Cancer Risk Estimation in Current and Past Smokers (6-year)
- Mayo Chronic Myelomonocytic Leukemia (CMML) Prognostic Model in Adults (conventional and SI units)
- MDACC Myelodysplastic Syndrome Prognostic Model
- Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma
- Multinational Association for Supportive Care in Cancer (MASCC) risk index for patients with neutropenic fever
- Multiple Myeloma Diagnostic Criteria
- Myelodysplastic Syndrome International Prognostic Scoring System
- Neurofibromatosis Type 1 Diagnostic Criteria
- Neurofibromatosis Type 2 Diagnostic Criteria (1987 NIH)
- Neurofibromatosis Type 2 Diagnostic Criteria (1991 NIH)
- Polycythemia Vera Diagnostic Criteria
- Revised International Prognostic Scoring System (IPSS-R) in Primary Myelodysplastic Syndrome in Adults
- Solitary Pulmonary Nodule Malignancy Risk (Brock abbreviated model)
- Solitary Pulmonary Nodule Malignancy Risk (Brock University)
- Solitary Pulmonary Nodule Malignancy Risk (Cummings prediction model: Bayesian approach)
- Solitary Pulmonary Nodule Malignancy Risk (Mayo Clinic model)
- Solitary Pulmonary Nodule Malignancy Risk (Veterans Affairs model)
- Splenic Marginal Zone Lymphoma Study Group (SMZLSG) Prognostic Index in Adults
- Veterans Affairs Frailty Index (VA-FI)
| Decision Trees |
- Barrett Esophagus Progression Risk TreeCalc
- Karnofsky Performance Status Score
- Smoking Cessation and Intervention TreeCalc
Legal Notices and Disclaimer All information contained in and produced by the EBMcalc system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. Click here for full notice and disclaimer. |